Cardiovascular Outcome Trials in Diabetes: What Have We Learnt?

Trends in Urology & Men's Health
doi 10.1002/tre.642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Chinese Investments in Africa: What Have We Learnt?

Management international
2018English

A Year of Guidelines: What Have We Learnt?

Australian and New Zealand Journal of Psychiatry
MedicinePsychiatryMental Health
2016English

Tau Imaging in Parkinsonism - What Have We Learnt So Far?

Movement Disorders Clinical Practice
Neurology
2018English

Policy Learning and Social Protection: What Have We Learnt?

International Social Security Review
SociologyFinancePublic AdministrationEconomicsPolitical ScienceEconometrics
2009English

P5-S6.26 Prevention With Positives in Nigeria: What Have We Learnt?

Sexually Transmitted Infections
DermatologyInfectious Diseases
2011English

S01.04 Lung Cancer Screening: 1999 to Date – What Have We Learnt?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The Re-Emergence of Tuberculosis: What Have We Learnt From Molecular Epidemiology?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2013English

Modelling Property Crime Using the British Crime Survey. What Have We Learnt?

British Journal of Criminology
ArtsHumanitiesForensic MedicineSocial PsychologyPathologyLaw
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy